Correction: Efficacy of GV1001 with Gemcitabine/capecitabine in Previously Untreated Patients with Advanced Pancreatic Ductal Adenocarcinoma Having High Serum Eotaxin Levels (KG4/2015): an Open-label, Randomised, Phase 3 Trial